RYANODINE |6-(1B1;,5aB2;,8aB2;,9-pentahydroxy-7B2;-isopropyl-2B2;,5B2;,8B2;-trimethylperhydro-8bB1;,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate |cas:15662-33-6|西域试剂

RYANODINE ,6-(1B1;,5aB2;,8aB2;,9-pentahydroxy-7B2;-isopropyl-2B2;,5B2;,8B2;-trimethylperhydro-8bB1;,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate ,≥98% (HPLC)

产品编号：SIGMA-559276| CAS NO：15662-33-6| 分子式：C25H35NO9| 分子量：493.5467

Ryanodine是可渗透细胞的兰尼碱受体调节剂。根据其浓度，Ryanodine可以刺激或抑制Ryanodine介导的Ca2+ 释放。在Ryania speciosa中发现的有毒二萜。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	包装	价格	库存与货期	购买量	操作
SIGMA-559276		￥3206.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

产品名称	RYANODINE
英文名称	6-(1B1;,5aB2;,8aB2;,9-pentahydroxy-7B2;-isopropyl-2B2;,5B2;,8B2;-trimethylperhydro-8bB1;,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate
CAS编号	15662-33-6
产品描述	Ryanodine是可渗透细胞的兰尼碱受体调节剂。根据其浓度，Ryanodine可以刺激或抑制Ryanodine介导的Ca2+ 释放。在Ryania speciosa中发现的有毒二萜。
产品沸点	714.2±60.0 °C at 760 mmHg
产品密度	1.6±0.1 g/cm3
产品闪点	385.7±32.9 °C
精确质量	493.231171
PSA	172.70000
LogP	3.86
外观性状	白色固体
蒸气压	0.0±2.4 mmHg at 25°C
折射率	1.685
靶点	Ryanodine receptor
体内研究	Ryanodine（100-5000 nM，30-120分钟）以剂量相关的方式不可逆地抑制快肌和慢肌的抽搐和强直张力。在浓度高于250 nM时，兰尼碱诱导缓慢发展的剂量依赖性挛缩，不能被5 mMCo2 +阻断。
储存条件	库房通风低温干燥,与食品原料分开储运

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品

符号	GHS07, GHS09
信号词	Warning
危害声明	H302 + H312-H410
警示性声明	P273-P280-P501
危害码 (欧洲)	Xn: Harmful;N: Dangerous for the environment;
风险声明 (欧洲)	R21/22
安全声明 (欧洲)	36/37-60-61
危险品运输编码	UN 3077 9
RTECS号	VM4025000

Name:	Ryanodine Material Safety Data Sheet
Synonym:	Ryanadol; 3-(1 H-pyrrole-2-carboxylate
CAS:	15662-33-6

Section 1 - Chemical Product MSDS Name:Ryanodine Material Safety Data Sheet
Synonym:Ryanadol; 3-(1 H-pyrrole-2-carboxylate

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
15662-33-6	Ryanodine		239-732-2

Hazard Symbols: XN
Risk Phrases: 20/22

Section 3 - HAZARDS IDENTIFICATION

EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed.
Inhalation:
Harmful if inhaled. The toxicological properties of this substance have not been fully investigated.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Deep freeze (below -20C).

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 15662-33-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 219-220 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: insoluble
Specific Gravity/Density:
Molecular Formula: C25H35NO9
Molecular Weight: 493.2463

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 15662-33-6: VM4025000 LD50/LC50:
CAS# 15662-33-6: Oral, mouse: LD50 = 650 mg/kg; Oral, rabbit: LD50 = 650 mg/kg; Oral, rat: LD50 = 750 mg/kg; Skin, rabbit: LD50 = >4 gm/kg.
Carcinogenicity:
Ryanodine - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/22 Harmful by inhalation and if swallowed.
Safety Phrases:
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 15662-33-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 15662-33-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 15662-33-6 is not listed on the TSCA inventory.
It is for research and development use only.

SECTION 16 - ADDITIONAL INFORMATION
N/A